HERBALIFE LTD (HLF)
Consumer Staples · Direct-selling nutrition and wellness products · NYSE
Global direct-selling nutrition company with 46 years of history selling weight management, protein, and wellness products through an independent distributor network in 95 markets worldwide.
What HERBALIFE LTD does
Herbalife is a global nutrition and wellness company that operates on a direct-selling business model, selling science-backed weight management, targeted nutrition, energy, sports, and outer nutrition products through a network of independent distributors and consumer members in 95 markets worldwide. The company's product portfolio includes its flagship Formula 1 Nutritional Shake Mix and other meal replacement, protein, dietary supplement, and skincare offerings. Members provide personalized coaching and education to customers while building their own sales organizations. With 46 years of operating history, the company generates revenue primarily from the sale of these products to and through its global network of independent members.
Themes: Weight management and meal replacement, Direct-selling distribution model, Sports nutrition and fitness supplements, Personalized nutrition coaching, Botanical and herbal ingredients, Metabolic health and weight-loss supplements, Global wellness and healthy lifestyle, Protein and sports nutrition
Fundamentals
- Price$12.65 as of 2026-08-21 close
- Market cap$1.3B as of 2026-08-21
- 1-year return+37.8% 2025-08-21 close $9.18 → 2026-08-21 close $12.65
- P/E7.68 as of 2026-08-24
- Net margin+3.2% as of 2026-08-24
- Gross margin+77.7% as of 2026-08-24
- ROE+170.7% as of 2026-08-24
- Debt / equity10.41 as of 2026-08-24
- Revenue growth (YoY)+5.5% as of 2026-08-24
- Revenue CAGR (3y)-1.1% SEC XBRL
- Beta0.84 as of 2026-08-24
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
Dividend: 1-year non-decreasing per-share dividend streak (SEC XBRL).
How HLF compares in its sector
- price-to-earnings ratiobottom 10% 97 covered Consumer Staples peers, as of 2026-08-24
- net profit marginmiddle range 116 covered Consumer Staples peers, as of 2026-08-24
- operating marginbottom 10% 116 covered Consumer Staples peers, as of 2026-08-24
- gross margintop 10% 116 covered Consumer Staples peers, as of 2026-08-24
- return on equitytop 10% 116 covered Consumer Staples peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 109 covered Consumer Staples peers
- free cash flow (absolute dollars, latest fiscal year)middle range 110 covered Consumer Staples peers, as of FY2025
Position among covered Consumer Staples companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which HLF reported a dividend payment is FY2014, while its reported financial statements run through FY2025. Coverage is therefore not assessed for the latest year — an FY2014 ratio would not describe HLF today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2014) is older than the latest year of reported financial statements (FY2025), so any ratio would describe an out-of-date year. Informational only — not financial advice.
How HERBALIFE LTD looks technically
HERBALIFE LTD (HLF) is trading 8.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 32 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 14, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 54, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive). It made a new 20-day low about 12 trading days ago. It is 38.0% below its highest point of the past year. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 6% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 8.7% below its 200-day average, the long-term trend line — a long-term downtrend | -8.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $12.33 | $12.33 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $13.86 | $13.86 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 11.3. It is the only labelling that fits, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 32 trading days ago — a "death cross", a bearish long-term signal | 32 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 14, below the 25 that marks a real trend) | 13.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 54, neither overbought (above 70) nor oversold (below 30) | 54.3 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($11.30 to $12.98) — its "stochastic" reading is 80 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 80.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $20.40 | $20.40 |
|---|---|---|
| From the 52-week high | it is 38.0% below its 52-week high (its highest price of the past year) | -38.0% |
| Above the 52-week low | it is 67.3% above its 52-week low (its lowest price of the past year) | +67.3% |
| Below the 52-week high | it is 38.0% below its highest point of the past year | 38.0% |
| Since a 20-day breakout | it made a new 20-day low about 12 trading days ago | 12 sessions |
| Since a 55-day breakout | it made a new 55-day low about 50 trading days ago | 50 sessions |
| All-time high | its highest closing price on record is $61.77 (set on 2019-02-05) | $61.77 |
| Given back of the 52-week move | over the past year its closes ranged ($7.75 to $19.96), and it has given back a bit over half of its rise from last year’s low — 60% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $12.02 to $12.41. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 59.9% |
| From the all-time high | it is 79.5% below its all-time high | -79.5% |
| Nearest price level | it is trading 1.0% above a support level at $12.52 — a price it turned at twice since 2025-12-30, most recently on 2026-06-12. Since 2024-08-21 it has 11 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.0% |
| All-time low | its lowest closing price on record is $3.03 (set on 2009-03-09) | $3.03 |
| Above the all-time low | it is 317.5% above its all-time low | +317.5% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 6% of the past ~6 months), which often precedes a bigger move | 6th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.5469 between its high and its low — about 4.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.5469 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $11.50 and $13.01 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $11.50 – $12.26 – $13.01 |
| Typical daily range (% of price) | its price moves about 4.3% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.3% |
| Stretch from the 200-day average | it is trading 2.2 daily ranges below its 200-day average price (8.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.2 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.07× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.3% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.3% |
|---|---|---|
| Gap filled | a 2.3% gap down opened on 2026-08-20 has been "filled" today — price traded back through the level the gap left behind, and it took 1 session to close | today |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 2.7 percentage points (the stock gained 5.1% while the market gained 2.3%) | +2.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 3.4 percentage points (the stock lost 0.3% while the market gained 3.1%) | -3.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 47.7 percentage points (the stock lost 36.6% while the market gained 11.1%) | -47.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 17.3 percentage points (the stock gained 37.8% while the market gained 20.5%) | +17.3% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thick, spanning 11.9% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 13% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $14.56 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | -13.1% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% above the average price paid since it last reported on 2026-08-05 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $12.05 — a volume-weighted average of daily closes over 13 sessions, not a true tick-by-tick VWAP. | +5.0% |
Price levels it has turned at before
HLF last closed at $12.65 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $12.52 | Support | 1.0% below the last close | turned there twice · 2025-12-30 to 2026-06-12 |
| $13.46 | Resistance | 6.4% above the last close | turned there three times · 2025-11-26 to 2026-07-07 |
| $11.61 | Support | 8.2% below the last close | turned there twice · 2025-12-08 to 2026-07-23 |
| $11.24 | Support | 11.2% below the last close | turned there twice · 2026-06-04 to 2026-08-06 |
| $17.56 | Resistance | 38.8% above the last close | turned there twice · 2026-01-22 to 2026-04-17 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $11.30.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · MACD just crossed bullish (12/26/9) · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low · bollinger bands
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.00 mean, 1=Strong Buy…5=Strong Sell) — 3 analysts
- Mean price target$17.00 range $9.00 – $25.00
Analyst estimates, as of 2026-08-21. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HLF
- Consensus EPS estimate$0.617 next reporting period, as of 2026-08-21
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Regulatory scrutiny of direct-selling business model and risk of legal challenges related to multi-level marketing structure, compliance with weight loss and health claims regulations, and international regulatory changes in 95 operating markets","High debt burden with long-term debt of approximately $1.98 billion as of March 2026, limiting financial flexibility and refinancing risk if interest rates remain elevated","Dependence on a network of independent distributors/members whose recruitment, retention, and compliance with company policies and regulations directly impacts revenue; changes in member behavior or regulatory restrictions on compensation structures could materially harm business"]
What changed in the latest 10-Q
AI-assisted comparison of HLF's 10-Q filed 2026-05-06 against the prior one filed 2025-11-05.
Management's Discussion & Analysis (MD&A)
- Added:
- Added new paragraph in 'Certain Factors Impacting Results' section discussing the war in the Middle East, its lack of direct material impact, and exposure to energy/oil market volatility and maritime restrictions in the Strait of Hormuz (filed 2026-05-06)
- Added reference to 'rising energy prices' as a factor in ongoing inflationary pressures (filed 2026-05-06)
- Removed:
- Removed entire 'Volume Points by Geographic Region' subsection that appeared in the older filing (filed 2025-11-05)
- Removed discussion about Management's decision to discontinue disclosure of Volume Points by Geographic Region going forward (filed 2025-11-05)
- Reworded:
- Changed reference from '2024 10-K' to '2025 10-K' in opening paragraph (filed 2026-05-06)
- Changed reference from 'December 31, 2024' to 'December 31, 2025' in opening paragraph (filed 2026-05-06)
- Changed 'the inflation' to 'inflation' in overview section (filed 2026-05-06)
- Changed reporting period from 'nine months ended September 30, 2025' to 'three months ended March 31, 2026' when discussing 2025 pricing actions (filed 2026-05-06)
- Changed reference from '2024' pricing actions to '2025' pricing actions (filed 2026-05-06)
- Changed asset threshold description from 'less than 1%' to 'approximately 1%' for Russia and Ukraine assets (filed 2026-05-06)
- Changed date reference from 'September 30, 2025' to 'March 31, 2026' for consolidated total assets calculation (filed 2026-05-06)
- Changed reference from '2024 10-K' to '2025 10-K' in Risk Factors cross-reference (filed 2026-05-06)
- Notes:
- Older filing text appears truncated at the end of the Presentation section, limiting full comparison of that portion
- Newer filing text also appears truncated at the end, preventing complete comparison of the Presentation section
Risk Factors
- Added:
- In newer filing (2026-05-06): 'Other operating income' line item appears in income statement with value of $(5.5) million for Q1 2026
- In newer filing (2026-05-06): 'Member compensation liabilities' line item in balance sheet (replaced 'Royalty overrides' from older filing)
- In newer filing (2026-05-06): Net loss attributable to noncontrolling interest of $(0.7) million in Q1 2026 income statement
- Removed:
- In older filing (2025-11-05): 'Royalty overrides' line item in balance sheet ($345.8 million at Sept 30, 2025) - replaced by 'Member compensation liabilities' in newer filing
- In older filing (2025-11-05): 'Other expense, net' line item in income statement - not present in newer filing
- Reworded:
- Balance sheet caption changed from 'September 30, 2025 and December 31, 2024' (older) to 'March 31, 2026 and December 31, 2025' (newer) reflecting different reporting periods
- Income statement caption changed from 'Three Months Ended and Nine Months Ended September 30, 2025 and 2024' (older) to 'Three Months Ended March 31, 2026 and March 31, 2025' (newer)
- Cash flow statement caption changed from 'Nine Months Ended September 30, 2025 and 2024' (older) to 'Three Months Ended March 31, 2026 and March 31, 2025' (newer)
- Notes:
- The two filings report different fiscal periods (Q1 2026 vs. Q3 2025 and nine-month periods), which accounts for most numerical differences and is not a substantive filing change
- The replacement of 'Royalty overrides' with 'Member compensation liabilities' appears to be a presentation/classification change rather than a new liability type
- Comparison of financial metrics across different quarters is not meaningful for assessing actual changes in company condition
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 0 open-market sales by insiders in the last 90 days.
- Last 90 days1 buy ($13572) · 0 sells — 1 buying insider
- Last 180 days1 buy ($13572) · 4 sells ($3M) — 1 buying, 2 selling insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-04. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HLF's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
HLF had 9,075,137 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
HLF had 8.66% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 7.9 days to cover at the same settlement.
- Reported short interest (shares) 9,075,137
- Short interest (% of shares outstanding) 8.66%
- Prior settlement (shares) 9,319,280
- Reported change -2.62%
- Days to cover (reported) 7.9
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Amway
- USANA Health Sciences (USNA)
- Mannatech
- Hum Nutrition
- Nutrilite (Amway subsidiary)
- GNC Holdings
- Nu Skin Enterprises (NUS)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HLF vs…
Frequently asked questions
What does HERBALIFE LTD (HLF) do?
Herbalife is a global nutrition and wellness company that operates on a direct-selling business model, selling science-backed weight management, targeted nutrition, energy, sports, and outer nutrition products through a network of independent distributors and consumer members in 95 markets worldwide. The company's product portfolio includes its flagship Formula 1 Nutritional Shake Mix and other meal replacement, protein, dietary supplement, and skincare offerings.
What sector is HERBALIFE LTD (HLF) in?
HERBALIFE LTD (HLF) is classified in the Consumer Staples sector. Its industry is Direct-selling nutrition and wellness products. It trades on NYSE.
Who are HERBALIFE LTD's (HLF) competitors?
Notable peers of HERBALIFE LTD (HLF) include Amway, USANA Health Sciences, Mannatech, Hum Nutrition and Nutrilite (Amway subsidiary). This peer set is informational only — not financial advice.
Is HERBALIFE LTD (HLF) overbought or oversold right now?
HERBALIFE LTD (HLF) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 54, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HLF come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.